Upgrade to SI Premium - Free Trial

Tecfidera IP the Major Risk of Biogen (BIIB) Takeout - Baird

August 3, 2016 7:17 AM
Baird analyst Brian Skorney weighed in on Biogen (NASDAQ: BIIB) amid reports Tuesday that the company is in talks with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Mergers and Acquisitions Rumors

Next Articles